Search
for
Sort by
Research 841–870 of 1000+
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Anticoronavirus Isoquinoline Alkaloids: Unraveling the Secrets of Their Structure–Activity Relationship
- Granzyme B in skin aging, injury and repair
- Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Successful management of Netherton syndrome using IVIG and dupilumab: A case report
- Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Autosomal Ichthyosis with Hypotrichosis Syndrome Displays Low Matriptase Proteolytic Activity and Is Phenocopied in ST14 Hypomorphic Mice
- Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Platelet Extracellular Vesicles Loaded Gelatine Hydrogels for Wound Care
- A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese population
- Dermal fibrosis in male pattern hair loss: a suggestive implication of mast cells
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
- Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial
- Forme létale de syndrome de Netherton au sein d’une famille multiplex consanguine
- Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
- A new tool for conditional gene manipulation in a subset of keratin‐expressing epithelia
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Translational perspectives in HTRA1-associated disorders: biomarkers, gene therapy, and future directions
- Case report - Hair shaft normalization and hair growth in SPINK5-syndromic epidermal differentiation disorder (Netherton syndrome) while on treatment with dupilumab: a novel therapeutic approach for Trichorrhexis invaginata
- Trichoscopy in Unveiling the Triad of Netherton Syndrome
- 565 Cutaneous delivery of LEKTI via an engineered strain of staphylococcus epidermidis for the treatment of netherton syndrome
- Érythrodermies néonatales et infantiles : apport de la biopsie cutanée précoce dans les formes graves
- The Dermal Papilla and Hair Follicle Regeneration: Engineering Strategies to Improve Dermal Papilla Inductivity
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biology
- Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes